The forecast for Musculo-Skeletal System Medicine Sales in Canada between 2024 and 2028 shows a steady upward trend. Starting at $24.5 USD PPP per capita in 2024, it is projected to reach $25.1 by 2028. This gradual increase represents a Compound Annual Growth Rate (CAGR) of approximately 0.61% over this five-year period. Year-on-year growth is consistent, ranging between 0.41% and 0.81%, demonstrating steady market expansion.

Future trends to watch for include:

Potential impacts of innovations in biotechnology on treatment effectiveness and market dynamics.
The effects of demographic shifts, particularly aging populations, on musculo-skeletal treatment demand.
Regulatory changes that may influence drug pricing and accessibility in Canada.